Farid Hashemi

3.3k total citations
40 papers, 2.4k citations indexed

About

Farid Hashemi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Farid Hashemi has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 16 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Farid Hashemi's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (8 papers). Farid Hashemi is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (8 papers). Farid Hashemi collaborates with scholars based in Iran, Türkiye and Pakistan. Farid Hashemi's co-authors include Kiavash Hushmandi, Milad Ashrafizadeh, Ali Zarrabi, Amirhossein Zabolian, Sepideh Mirzaei, Pooyan Makvandi, Haroon Khan, Alan Prem Kumar, Masoud Najafi and Mohammad Gholami and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carbohydrate Polymers and Life Sciences.

In The Last Decade

Farid Hashemi

40 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farid Hashemi Iran 27 1.5k 870 356 338 278 40 2.4k
Jia Zhang China 27 1.2k 0.8× 616 0.7× 341 1.0× 280 0.8× 291 1.0× 138 2.7k
Nasser Samadi Iran 34 1.6k 1.1× 502 0.6× 412 1.2× 333 1.0× 247 0.9× 98 2.9k
Maliheh Entezari Iran 32 2.0k 1.3× 1.2k 1.4× 468 1.3× 258 0.8× 302 1.1× 136 3.2k
Bilal Bin Hafeez United States 36 1.9k 1.3× 699 0.8× 551 1.5× 378 1.1× 292 1.1× 82 3.7k
Sheema Khan United States 28 1.5k 1.0× 584 0.7× 593 1.7× 632 1.9× 448 1.6× 74 3.0k
Mateusz Kciuk Poland 19 1.3k 0.9× 378 0.4× 671 1.9× 338 1.0× 383 1.4× 51 2.7k
Shu‐Fen Peng Taiwan 31 1.8k 1.2× 307 0.4× 279 0.8× 537 1.6× 270 1.0× 109 3.4k
Sepideh Mirzaei Iran 39 2.5k 1.6× 1.6k 1.8× 633 1.8× 405 1.2× 484 1.7× 69 4.0k
Solmaz Shirjang Iran 16 1.5k 1.0× 823 0.9× 498 1.4× 223 0.7× 227 0.8× 18 2.4k
Amareshwar T.K. Singh United States 17 1.2k 0.8× 368 0.4× 458 1.3× 186 0.6× 150 0.5× 32 2.3k

Countries citing papers authored by Farid Hashemi

Since Specialization
Citations

This map shows the geographic impact of Farid Hashemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farid Hashemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farid Hashemi more than expected).

Fields of papers citing papers by Farid Hashemi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farid Hashemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farid Hashemi. The network helps show where Farid Hashemi may publish in the future.

Co-authorship network of co-authors of Farid Hashemi

This figure shows the co-authorship network connecting the top 25 collaborators of Farid Hashemi. A scholar is included among the top collaborators of Farid Hashemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farid Hashemi. Farid Hashemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashemi, Farid, Najma Farahani, Safa Tahmasebi, et al.. (2025). Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies. Pathology - Research and Practice. 269. 155946–155946. 2 indexed citations
2.
Mirzaei, Sepideh, Mohammad Gholami, Kiavash Hushmandi, et al.. (2022). The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of Hematology & Oncology. 15(1). 18–18. 130 indexed citations
3.
Ashrafizadeh, Milad, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.. (2022). Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. Journal of Experimental & Clinical Cancer Research. 41(1). 105–105. 111 indexed citations
4.
Mirzaei, Sepideh, Mahmood Khaksary Mahabady, Farid Hashemi, et al.. (2021). Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytotherapy Research. 36(1). 189–213. 155 indexed citations
5.
Zarrabi, Ali, Mohammad Gholami, Sepideh Mirzaei, et al.. (2021). Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules. 11(2). 304–304. 65 indexed citations
6.
Mirzaei, Sepideh, Ali Zarrabi, Farid Hashemi, et al.. (2021). Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants. 10(3). 349–349. 90 indexed citations
7.
Soleymani, Leyla, Ali Zarrabi, Farid Hashemi, et al.. (2021). Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks. Current Cancer Drug Targets. 21(9). 749–767. 28 indexed citations
8.
Mirzaei, Sepideh, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.. (2021). Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. Life Sciences. 288. 119948–119948. 41 indexed citations
9.
Mirzaei, Sepideh, Hamidreza Saebfar, Mohammad Gholami, et al.. (2021). MicroRNAs regulating SOX2 in cancer progression and therapy response. Expert Reviews in Molecular Medicine. 23. e13–e13. 22 indexed citations
10.
Mirzaei, Sepideh, Mohammad Gholami, Farid Hashemi, et al.. (2021). Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance. Pharmacological Research. 167. 105575–105575. 107 indexed citations
11.
Zarrabi, Ali, Farid Hashemi, Amirhossein Zabolian, et al.. (2021). The role of SOX family transcription factors in gastric cancer. International Journal of Biological Macromolecules. 180. 608–624. 58 indexed citations
12.
Ashrafizadeh, Milad, Ali Zarrabi, Kiavash Hushmandi, et al.. (2020). Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Combinatorial Science. 22(12). 669–700. 79 indexed citations
13.
Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics. 12(11). 1084–1084. 97 indexed citations
14.
Ashrafizadeh, Milad, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.. (2020). C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors. Current Cancer Drug Targets. 21(1). 2–20. 23 indexed citations
15.
Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines. 8(5). 110–110. 69 indexed citations
16.
Ashrafizadeh, Milad, Ali Zarrabi, Kiavash Hushmandi, et al.. (2020). Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators. Cellular Signalling. 78. 109871–109871. 115 indexed citations
17.
Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sciences. 256. 117984–117984. 122 indexed citations
18.
Hushmandi, Kiavash, Saied Bokaie, Mehrdad Hashemi, et al.. (2020). A review of medications used to control and improve the signs and symptoms of COVID-19 patients. European Journal of Pharmacology. 887. 173568–173568. 5 indexed citations
19.
Hashemi, Farid, et al.. (2016). Sexualisierte Gewalt, Traumatisierung und Flucht. 23(12). 87–90. 1 indexed citations
20.
Dirandeh, E., Armin Towhidi, Zarbakht Ansari Pirsaraei, et al.. (2013). Plasma concentrations of PGFM and uterine and ovarian responses in early lactation dairy cows fed omega-3 and omega-6 fatty acids. Theriogenology. 80(2). 131–137. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia Zhang Breakdown of academic impact, for papers by Nasser Samadi Breakdown of academic impact, for papers by Maliheh Entezari Breakdown of academic impact, for papers by Bilal Bin Hafeez Breakdown of academic impact, for papers by Sheema Khan Breakdown of academic impact, for papers by Mateusz Kciuk Breakdown of academic impact, for papers by Shu‐Fen Peng Breakdown of academic impact, for papers by Sepideh Mirzaei Breakdown of academic impact, for papers by Solmaz Shirjang Breakdown of academic impact, for papers by Amareshwar T.K. Singh
Rankless by CCL
2026